speb/financial-data huggingface dataset:
Financial ratios for JIOFIN.NS — quarterly report dated 2025-03-31
Total revenue: 36844750.99368716
Gross profit: 30444236.614449378
Operating income: 38839139.58382043
Net income: 36954641.10357727
Capital expenditures: 0
Depreciation & amortization: 673369.1840074818
Net tangible assets: 14419141921.907879
Owner earnings: 37628010.28758475
Return on net tangible assets (%): 0.2609587345167484
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.6509511028124635
P/E ratio: 118.41953435873211
Shares outstanding: 6603141623
Book value: 14437277297.170914
P/B ratio: 1.2124589150163985
Market cap (USD): 17504605567.51873
Debt to equity: 0.032146667835930856
Current ratio: 6.561187746510535
Quick ratio: 6.561187746510535
Effective tax rate (%): 20.13592380182411
Interest coverage ratio: 43.428758169934646
COGS to revenue (%): 17.371577244027034
Buyback yield (%): 0
Retained earnings: 1526746551.3210194
Receivables turnover: 21.08160535117057
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.2534882193175526
Revenue growth (%): 27.977294131277453
Rule of 40 score: 27.977294131277453
Financial ratios for JIOFIN.NS — quarterly report dated 2025-06-30
Total revenue: 48729230.0491458
Gross profit: 41277790.77931196
Operating income: 52743973.788907096
Net income: 37989702.78492863
Capital expenditures: 0
Depreciation & amortization: 717294.6407676106
Owner earnings: 38706997.42569624
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.817458460098292
P/E ratio: 230.6136105470882
Shares outstanding: 6603141623
Market cap (USD): 25207218851.948517
Effective tax rate (%): 22.509964913955656
Interest coverage ratio: 4.562246963562753
COGS to revenue (%): 15.291518586110845
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 32.255555363896704
Rule of 40 score: 32.255555363896704
Financial ratios for JIOFIN.NS — quarterly report dated 2025-12-31
Total revenue: 76458727.86008689
Gross profit: 65324718.725632176
Operating income: 60973599.19795032
Net income: 29963239.389551077
Capital expenditures: 0
Depreciation & amortization: 841038.2087557091
Owner earnings: 30804277.598306786
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.2856188036092235
P/E ratio: 155.78144466727215
Shares outstanding: 6603141623
Market cap (USD): 21695406279.423527
Effective tax rate (%): 27.516235953542267
Interest coverage ratio: 2.577267162633016
COGS to revenue (%): 14.562116642627155
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 56.90526565466874
Rule of 40 score: 56.90526565466874
Financial ratios for KMDA — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 1809354.8387096773
Buffett classification: The Gruesome
Stock price: 6.21
Shares outstanding: 57694272
Market cap (USD): 358281429.12
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KMDA — annual report dated 2022-12-31
Total revenue: 36744034.09090909
Gross profit: 13267897.727272727
Operating income: 1287500
Net income: -659375
Capital expenditures: 1075000
Operating cash flow: 8121022.7272727275
Depreciation & amortization: 3453125
Net tangible assets: 8241761.363636363
Owner earnings: 1718750
Capex to operating income (%): 83.49514563106796
Buffett classification: The Gruesome
Stock price: 3.78
Shares outstanding: 57694272
Book value: 50005681.81818182
P/B ratio: 4.361191373271219
Market cap (USD): 218084348.16
Debt to equity: 0.11703215543688217
Current ratio: 1.8361402813552605
Quick ratio: 0.8782511062677499
Interest coverage ratio: 4.958424507658643
COGS to revenue (%): 63.891015084390624
R&D to revenue (%): 10.184089872350953
SG&A to revenue (%): 19.37389341188659
Free cash flow (dilution-adjusted): 6718465.909090909
Buyback yield (%): 0
Retained earnings: -13773863.636363637
Inventory turnover: 1.1395396941406843
Receivables turnover: 4.561417739375772
Capitalized R&D asset: 3742045.4545454546
ROCI (R&D-adjusted, %): 5.1235475371309676
FCF margin (%): 18.284508152993297
Rule of 40 score: 18.284508152993297
Financial ratios for KMDA — annual report dated 2023-12-31
Total revenue: 39369889.50276243
Gross profit: 15328729.281767955
Operating income: 2780110.497237569
Net income: 2288397.7900552484
Capital expenditures: 1614088.3977900553
Operating cash flow: 1191988.950276243
Depreciation & amortization: 3512154.6961325966
Net tangible assets: 28747513.812154695
Owner earnings: 4186464.08839779
Return on net tangible assets (%): 14.56287356100936
Capex to operating income (%): 58.058426073131955
Buffett classification: The Good
Stock price: 5.77
P/E ratio: 145.4711898808305
Shares outstanding: 57694272
Book value: 67409116.02209945
P/B ratio: 4.93844110536716
Market cap (USD): 332895949.44
Debt to equity: 0.036152626208400096
Current ratio: 3.427136894319763
Quick ratio: 1.6430342991954512
Effective tax rate (%): 1.7202515126349505
Interest coverage ratio: 7.75346687211094
COGS to revenue (%): 61.06484047741003
R&D to revenue (%): 9.776240360934331
SG&A to revenue (%): 19.259888155263507
Free cash flow (dilution-adjusted): -787016.5745856353
Buyback yield (%): 0
Retained earnings: -11104972.375690607
Inventory turnover: 0.9836119305145855
Receivables turnover: 6.694804584742578
Capitalized R&D asset: 6356065.482169764
ROCI (R&D-adjusted, %): 4.5191068224513495
Rosenberg metric: 0.5507232821001522
FCF margin (%): -1.9990317080529614
Revenue growth (%): 7.14634491508651
Rule of 40 score: 5.147313207033548
Financial ratios for KMDA — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 876216.2162162162
Buffett classification: The Gruesome
Stock price: 5.07
Shares outstanding: 57694272
Market cap (USD): 292509959.04
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KMDA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.75
Shares outstanding: 57694272
Market cap (USD): 331742064
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KMDA — annual report dated 2024-12-31
Total revenue: 44096712.32876712
Gross profit: 19169041.09589041
Operating income: 5493424.657534246
Net income: 3962191.780821918
Capital expenditures: 2942191.780821918
Operating cash flow: 13039452.05479452
Depreciation & amortization: 3783013.698630137
Net tangible assets: 34874246.57534247
Owner earnings: 4803013.698630137
Return on net tangible assets (%): 13.772379822611184
Capex to operating income (%): 53.55842601366516
Buffett classification: The Good
Stock price: 5.75
P/E ratio: 83.72690731572396
Shares outstanding: 57694272
Book value: 71086027.39726028
P/B ratio: 4.6667689297937285
Market cap (USD): 331742064
Debt to equity: 0.042634045570869174
Current ratio: 3.7325517827856407
Quick ratio: 2.1366701087286644
Effective tax rate (%): -8.459577021148942
Interest coverage ratio: 30.38030303030303
COGS to revenue (%): 56.52954589227912
R&D to revenue (%): 9.434431169347574
SG&A to revenue (%): 19.157145253583348
Free cash flow (dilution-adjusted): 9857534.246575342
Buyback yield (%): 0
Retained earnings: -7051506.849315069
Inventory turnover: 1.1543663329907765
Receivables turnover: 6.938526533603483
Capitalized R&D asset: 7973908.641111027
ROCI (R&D-adjusted, %): 5.948985276776928
Rosenberg metric: 0.9977699538594192
FCF margin (%): 22.35435189154598
Revenue growth (%): 12.00618768735185
Rule of 40 score: 34.36053957889783
Financial ratios for KMDA — quarterly report dated 2025-03-31
Total revenue: 11928997.2899729
Gross profit: 5623035.230352304
Operating income: 2112466.124661247
Net income: 1074254.7425474254
Capital expenditures: 395663.9566395664
Operating cash flow: -139024.39024390245
Depreciation & amortization: 978590.7859078591
Net tangible assets: 32580487.80487805
Owner earnings: 1657181.571815718
Return on net tangible assets (%): 5.0864234499509235
Capex to operating income (%): 18.729955099422703
Buffett classification: The Great
Stock price: 6.42
P/E ratio: 86.19864813481333
Shares outstanding: 57694272
Book value: 68281029.8102981
P/B ratio: 5.424599296013208
Market cap (USD): 370397226.24
Debt to equity: 0.044047198529907884
Current ratio: 3.3042929514260173
Quick ratio: 1.9307237891563098
Effective tax rate (%): 40.05746257371843
Interest coverage ratio: 40.598958333333336
COGS to revenue (%): 52.86246535508201
R&D to revenue (%): 9.646053887046207
SG&A to revenue (%): 19.782816120677904
Free cash flow (dilution-adjusted): -584281.8428184282
Buyback yield (%): 0
Retained earnings: -9026558.265582656
Inventory turnover: 0.296957553791572
Receivables turnover: 1.2987725716983358
Capitalized R&D asset: 1150677.5067750677
ROCI (R&D-adjusted, %): 3.296783988615303
FCF margin (%): -4.897996274251443
Rule of 40 score: -4.897996274251443
Financial ratios for KMDA — quarterly report dated 2025-06-30
Total revenue: 13201769.911504425
Gross profit: 5583775.811209439
Operating income: 2085840.7079646017
Net income: 2175811.209439528
Capital expenditures: 594100.2949852507
Operating cash flow: 2366076.6961651915
Depreciation & amortization: 1105014.7492625369
Net tangible assets: 38348377.581120946
Owner earnings: 2686725.6637168145
Return on net tangible assets (%): 7.0060999530772845
Capex to operating income (%): 28.482534295007778
Buffett classification: The Good
Stock price: 7.52
P/E ratio: 133.49296040431292
Shares outstanding: 57694272
Book value: 76682595.87020649
P/B ratio: 5.657879998929041
Market cap (USD): 433860925.44
Debt to equity: 0.04391161513190795
Current ratio: 4.00377943810897
Quick ratio: 2.210643596801678
Effective tax rate (%): -28.211367981922475
Interest coverage ratio: 36.828125
COGS to revenue (%): 57.70433927693613
R&D to revenue (%): 7.192653170666308
SG&A to revenue (%): 19.272020378066763
Free cash flow (dilution-adjusted): 1743952.8023598818
Buyback yield (%): 0
Retained earnings: -7649557.522123894
Inventory turnover: 0.31463589956017984
Receivables turnover: 1.2712398806987646
Capitalized R&D asset: 1720511.451663189
ROCI (R&D-adjusted, %): 2.4119359664139415
Rosenberg metric: -0.034118524879220576
FCF margin (%): 13.209992402913704
Revenue growth (%): 10.669569206804784
Rule of 40 score: 23.879561609718486
Financial ratios for KMDA — quarterly report dated 2025-09-30
Total revenue: 14202416.918429002
Gross profit: 5970392.749244713
Operating income: 2361329.305135952
Net income: 1600000
Capital expenditures: 1084290.0302114803
Operating cash flow: 3146827.7945619333
Depreciation & amortization: 1135951.66163142
Net tangible assets: 41006948.64048338
Owner earnings: 1651661.63141994
Return on net tangible assets (%): 4.027760382515676
Capex to operating income (%): 45.918628454452396
Buffett classification: The Good
Stock price: 6.74
P/E ratio: 80.17610422816907
Shares outstanding: 57694272
Book value: 80130513.59516616
P/B ratio: 4.852825419846776
Market cap (USD): 388859393.28000003
Debt to equity: 0.04324515895517886
Current ratio: 4.028973388799464
Quick ratio: 2.243472625791751
Effective tax rate (%): 16.82110884246898
Interest coverage ratio: 35.366515837104075
COGS to revenue (%): 57.962135715805154
R&D to revenue (%): 5.607317592001702
SG&A to revenue (%): 19.83407785577537
Free cash flow (dilution-adjusted): 2027190.332326284
Buyback yield (%): 0
Retained earnings: -6234441.087613293
Inventory turnover: 0.3190146698980249
Receivables turnover: 1.3308232363265766
Capitalized R&D asset: 1812301.7394152766
ROCI (R&D-adjusted, %): 2.1635915052700945
Rosenberg metric: 0.4071548368871012
FCF margin (%): 14.27355881727292
Revenue growth (%): 7.579642832985467
Rule of 40 score: 21.853201650258388
Financial ratios for KMDA — quarterly report dated 2025-12-31
Total revenue: 14049685.534591194
Gross profit: 5335534.591194969
Operating income: 1116666.6666666665
Net income: 1120125.786163522
Capital expenditures: 872641.5094339622
Operating cash flow: 2379245.283018868
Depreciation & amortization: 1195283.0188679246
Net tangible assets: 44861949.68553459
Owner earnings: 1442767.2955974846
Return on net tangible assets (%): 3.216015589404253
Capex to operating income (%): 78.14700084483245
Buffett classification: The Gruesome
Stock price: 6.85
P/E ratio: 66.1964942724657
Shares outstanding: 57694272
Book value: 84613207.5471698
P/B ratio: 4.670733738343182
Market cap (USD): 395205763.2
Debt to equity: 0.04296651428996172
Current ratio: 4.0738279107059965
Quick ratio: 2.2815546271679956
Effective tax rate (%): 24.757076468103083
Interest coverage ratio: 13.710424710424707
COGS to revenue (%): 62.02381485294776
R&D to revenue (%): 6.4774609427458705
SG&A to revenue (%): 24.676574600474506
Free cash flow (dilution-adjusted): 1362578.6163522012
Buyback yield (%): 0
Retained earnings: -5369182.3899371065
Inventory turnover: 0.3262305310620063
Receivables turnover: 1.5490066913982594
Capitalized R&D asset: 1756987.872361498
ROCI (R&D-adjusted, %): 1.0773554627152755
Rosenberg metric: -0.7971853198576079
FCF margin (%): 9.698285509646807
Revenue growth (%): -1.075390088285778
Rule of 40 score: 8.62289542136103
Financial ratios for KMDA — annual report dated 2025-12-31
Total revenue: 56748427.672955975
Gross profit: 24027358.490566038
Operating income: 8249371.069182389
Net income: 6351572.327044025
Capital expenditures: 3093710.6918238993
Operating cash flow: 8015723.270440252
Depreciation & amortization: 4691194.968553459
Net tangible assets: 44861949.68553459
Owner earnings: 7949056.603773585
Return on net tangible assets (%): 17.718928088265187
Capex to operating income (%): 37.50238249533031
Buffett classification: The Good
Stock price: 6.85
P/E ratio: 62.221721307852256
Shares outstanding: 57694272
Book value: 84613207.5471698
P/B ratio: 4.670733738343182
Market cap (USD): 395205763.2
Debt to equity: 0.04296651428996172
Current ratio: 4.0738279107059965
Quick ratio: 2.2815546271679956
Effective tax rate (%): 13.930199855115694
Interest coverage ratio: 30.362268518518515
COGS to revenue (%): 57.65986922309653
R&D to revenue (%): 7.201041782112378
SG&A to revenue (%): 18.752632162252024
Free cash flow (dilution-adjusted): 4653773.58490566
Buyback yield (%): 0
Retained earnings: -5369182.3899371065
Inventory turnover: 1.224974394594022
Receivables turnover: 6.256630724959262
Capitalized R&D asset: 8143996.908181241
ROCI (R&D-adjusted, %): 7.392381271119103
Rosenberg metric: 1.1677878492305591
FCF margin (%): 8.200709298459492
Revenue growth (%): 28.690835837970912
Rule of 40 score: 36.8915451364304
Financial ratios for LIFE.OL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.1311288483466364
Shares outstanding: 408415644
Market cap (USD): 870386361.0444698
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LIFE.OL — annual report dated 2022-12-31
Total revenue: 686019.0283400809
Operating income: -1710955.2631578946
Net income: -1740978.3400809716
Capital expenditures: 577758.9068825911
Operating cash flow: -1842709.817813765
Depreciation & amortization: 231202.63157894736
Net tangible assets: 4349514.27125506
Owner earnings: -2087534.6153846153
Return on net tangible assets (%): -47.994660672357185
Buffett classification: The Gruesome
Stock price: 2.0020242914979756
Shares outstanding: 408415644
Book value: 5712112.246963562
P/B ratio: 143.14460307576047
Market cap (USD): 817658040.3157895
Debt to equity: 0.14696574253421182
Current ratio: 5.539215063587868
Quick ratio: 5.539215063587868
Interest coverage ratio: -26537.26530612245
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -2420468.724696356
Buyback yield (%): 0
Retained earnings: -3381149.4939271254
Receivables turnover: 5.128400147090646
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -25.922263868737293
FCF margin (%): -352.82821972927184
Rule of 40 score: -352.82821972927184
Financial ratios for LIFE.OL — annual report dated 2023-12-31
Total revenue: 418664.047151277
Operating income: -3472298.6247544205
Net income: -3458349.705304519
Capital expenditures: 119351.6699410609
Operating cash flow: -3667092.3379174853
Depreciation & amortization: 319548.1335952849
Net tangible assets: 5293909.626719058
Owner earnings: -3258153.2416502945
Return on net tangible assets (%): -61.54531284791804
Buffett classification: The Gruesome
Stock price: 4.81532416502947
Shares outstanding: 408415644
Book value: 6527996.070726916
P/B ratio: 301.26453794116316
Market cap (USD): 1966653719.9292731
Debt to equity: 0.09705815965691068
Current ratio: 6.023135521489701
Quick ratio: 6.023135521489701
Interest coverage ratio: -181.27179487179487
COGS to revenue (%): 0
R&D to revenue (%): 61.12153918348193
SG&A to revenue (%): 189.5354293758799
Free cash flow (dilution-adjusted): -4149017.6817288804
Buyback yield (%): 0
Retained earnings: -6629862.4754420435
Receivables turnover: 1.060462801691963
Capitalized R&D asset: 255893.90962671908
ROCI (R&D-adjusted, %): -42.8923883174668
FCF margin (%): -991.013608634444
Revenue growth (%): -38.97194831981653
Rule of 40 score: -1029.9855569542606
Financial ratios for LIFE.OL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.1040076335877864
Shares outstanding: 408415644
Market cap (USD): 859309632.6526718
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LIFE.OL — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.0802469135802468
Shares outstanding: 408415644
Market cap (USD): 441189738.88888884
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LIFE.OL — annual report dated 2024-12-31
Total revenue: 218799.64695498676
Operating income: -7482877.3168579
Net income: -6333362.753751103
Capital expenditures: 1126654.8984995587
Operating cash flow: -5784377.758164166
Depreciation & amortization: 434598.4112974404
Net tangible assets: 5427360.988526037
Owner earnings: -7025419.240953221
Return on net tangible assets (%): -129.44448058284004
Buffett classification: The Gruesome
Stock price: 1.0802469135802468
Shares outstanding: 408415644
Book value: 6529744.0423654
P/B ratio: 67.566161250184
Market cap (USD): 441189738.88888884
Debt to equity: 0.14684653023708472
Current ratio: 2.543671165811036
Quick ratio: 2.543671165811036
Interest coverage ratio: -181.5438972162741
COGS to revenue (%): 0
R&D to revenue (%): 784.5098830173457
SG&A to revenue (%): 633.4812424364662
Free cash flow (dilution-adjusted): -7187202.118270079
Buyback yield (%): 0
Retained earnings: -1418181.8181818181
Receivables turnover: 1.125794732061762
Capitalized R&D asset: 1887953.7738188338
ROCI (R&D-adjusted, %): -69.60096905922003
FCF margin (%): -3284.832593787817
Revenue growth (%): -47.73861083993981
Rule of 40 score: -3332.5712046277567
Financial ratios for LIFE.OL — quarterly report dated 2025-03-31
Total revenue: 381.6793893129771
Operating income: -2387022.9007633585
Net income: -1924618.320610687
Capital expenditures: 168893.12977099235
Operating cash flow: -1412500
Depreciation & amortization: 143320.61068702288
Net tangible assets: 3951526.717557252
Owner earnings: -1950190.8396946564
Return on net tangible assets (%): -49.35284458611031
Buffett classification: The Gruesome
Stock price: 1.0353053435114503
Shares outstanding: 408415644
Book value: 5104389.312977099
P/B ratio: 82.83750957864433
Market cap (USD): 422834898.6068702
Debt to equity: 0.18717987063969793
Current ratio: 1.8921728194125915
Quick ratio: 1.8921728194125915
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -1581393.1297709923
Buyback yield (%): 0
Retained earnings: -3434732.824427481
Receivables turnover: 0.00037351760201699503
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -40.65196548418025
FCF margin (%): -414325
Rule of 40 score: -414325
Financial ratios for LIFE.OL — quarterly report dated 2025-06-30
Total revenue: 695.1340615690168
Operating income: -2206454.816285998
Net income: -1321847.0705064547
Capital expenditures: 43396.22641509434
Operating cash flow: -1373286.991062562
Depreciation & amortization: 141608.73882820256
Net tangible assets: 4697219.463753724
Owner earnings: -1223634.5580933467
Return on net tangible assets (%): -26.0501892137587
Buffett classification: The Gruesome
Stock price: 0.5680238331678252
Shares outstanding: 408415644
Book value: 5848262.164846078
P/B ratio: 39.668163480268966
Market cap (USD): 231989819.6305859
Debt to equity: 0.16131223256129865
Current ratio: 3.343108504398827
Quick ratio: 3.343108504398827
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -1438232.373386296
Buyback yield (%): 0
Retained earnings: -4786693.14796425
Receivables turnover: 0.000675936655079181
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -33.37037982668249
FCF margin (%): -206900.00000000006
Revenue growth (%): 82.1251241310824
Rule of 40 score: -206817.87487586896
Financial ratios for LIFE.OL — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -6601102.204408817
Net income: -6489078.156312625
Capital expenditures: 299599.19839679357
Operating cash flow: -2219138.276553106
Depreciation & amortization: 260220.44088176353
Net tangible assets: -1785971.9438877755
Owner earnings: -6528456.913827655
Buffett classification: The Gruesome
Stock price: 0.8597194388777555
Shares outstanding: 408415644
Book value: -667434.8697394785
Market cap (USD): 351122868.28857714
Debt to equity: -6.889656207776615
Current ratio: 0.21962898798980007
Quick ratio: 0.21962898798980007
Free cash flow (dilution-adjusted): -2526052.104208417
Buyback yield (%): 0
Retained earnings: -10480661.32264529
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -193.22754736903852
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for LIFE.OL — quarterly report dated 2025-12-31
Total revenue: 406.81293532338304
Operating income: -1677611.9402985075
Net income: -2117810.9452736317
Capital expenditures: 125870.64676616914
Operating cash flow: -4742686.567164179
Depreciation & amortization: 246069.65174129352
Net tangible assets: -3860099.502487562
Owner earnings: -1997611.9402985075
Buffett classification: The Gruesome
Stock price: 0.11354581673306773
Shares outstanding: 408415644
Book value: -2789452.7363184076
Market cap (USD): 46373887.86454183
Debt to equity: -3.4658272098166516
Current ratio: 0.25892953040157524
Quick ratio: 0.25892953040157524
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -4874228.855721393
Buyback yield (%): 0
Retained earnings: -3736716.4179104473
Receivables turnover: 0.05241628205128205
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -149.84002843938865
FCF margin (%): -1198149.9191629142
Rule of 40 score: -1198149.9191629142
Financial ratios for LIFE.OL — annual report dated 2025-12-31
Total revenue: 455.63084577114427
Operating income: -12931343.28358209
Net income: -11891840.796019899
Capital expenditures: 642985.0746268657
Operating cash flow: -10982189.054726368
Depreciation & amortization: 795820.895522388
Net tangible assets: -3860099.502487562
Owner earnings: -11739004.975124376
Buffett classification: The Gruesome
Stock price: 0.11354581673306773
Shares outstanding: 408415644
Book value: -2789452.7363184076
Market cap (USD): 46373887.86454183
Debt to equity: -3.4658272098166516
Current ratio: 0.25892953040157524
Quick ratio: 0.25892953040157524
Interest coverage ratio: -51.48969889064977
COGS to revenue (%): 0
R&D to revenue (%): 1483788.2636069611
SG&A to revenue (%): 339936.5376090009
Free cash flow (dilution-adjusted): -11693233.83084577
Buyback yield (%): 0
Retained earnings: -3736716.4179104473
Receivables turnover: 0.058706282051282054
Capitalized R&D asset: 7995100.257529374
ROCI (R&D-adjusted, %): -99.63841511161282
FCF margin (%): -2566383.277026658
Revenue growth (%): -99.7917588752486
Rule of 40 score: -2566483.0687855333
Financial ratios for MBX.TO — annual report dated 2021-09-30
Capital expenditures: 0
Depreciation & amortization: 77658.59375
Buffett classification: The Gruesome
Stock price: 0.4921875
Shares outstanding: 137501156
Market cap (USD): 67676350.21875
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MBX.TO — annual report dated 2022-09-30
Total revenue: 13924263.503649633
Gross profit: 8120322.627737226
Operating income: 1905264.9635036495
Net income: 1305612.4087591239
Capital expenditures: 1478567.8832116788
Operating cash flow: 2529342.335766423
Depreciation & amortization: 756496.3503649634
Net tangible assets: 17109735.03649635
Owner earnings: 583540.8759124083
Return on net tangible assets (%): 3.4105780987705057
Capex to operating income (%): 77.60431811503507
Buffett classification: The Gruesome
Stock price: 0.3722627737226277
P/E ratio: 39.20502086164784
Shares outstanding: 137501156
Book value: 18203397.81021898
P/B ratio: 2.811923480235803
Market cap (USD): 51186561.72262774
Debt to equity: 0.23350782149237798
Current ratio: 8.454327281315635
Quick ratio: 6.460409859042806
Effective tax rate (%): 4.1391847359188985
Interest coverage ratio: 3.157923199767712
COGS to revenue (%): 41.68221087162822
R&D to revenue (%): 9.432020700514322
SG&A to revenue (%): 34.36216810219582
Free cash flow (dilution-adjusted): 576545.9854014597
Buyback yield (%): 0
Retained earnings: -26913818.24817518
Inventory turnover: 1.5045448180861771
Receivables turnover: 6.175421382369193
Capitalized R&D asset: 1313339.4160583941
ROCI (R&D-adjusted, %): 11.797038351352702
FCF margin (%): 4.1405851393888335
Rule of 40 score: 4.1405851393888335
Financial ratios for MBX.TO — annual report dated 2023-09-30
Total revenue: 12233167.407407407
Gross profit: 5541728.888888888
Operating income: -2026986.6666666665
Net income: -29246.666666666664
Capital expenditures: 752764.4444444444
Operating cash flow: -810785.9259259258
Depreciation & amortization: 857162.2222222221
Net tangible assets: 14963754.814814813
Owner earnings: 75151.11111111112
Buffett classification: The Gruesome
Stock price: 0.2296296296296296
Shares outstanding: 137501156
Book value: 18240360.74074074
P/B ratio: 1.7310150810451401
Market cap (USD): 31574339.525925923
Debt to equity: 0.26986653569676394
Current ratio: 5.126966290585024
Quick ratio: 3.8046426825920903
Interest coverage ratio: -3.260071147921437
COGS to revenue (%): 54.69914941625608
R&D to revenue (%): 12.393386383200111
SG&A to revenue (%): 48.50070022142595
Free cash flow (dilution-adjusted): -2108230.3703703703
Buyback yield (%): 2.6164307888765395
Retained earnings: -27341788.148148146
Inventory turnover: 1.5704786709251044
Receivables turnover: 3.954652700634597
Capitalized R&D asset: 2396041.112462828
ROCI (R&D-adjusted, %): -5.683468419983304
Rosenberg metric: -1.963387154393977
FCF margin (%): -17.233724514337947
Revenue growth (%): -12.144959019189635
Rule of 40 score: -29.37868353352758
Financial ratios for MBX.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.2518518518518518
Shares outstanding: 137501156
Market cap (USD): 34629920.770370364
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MBX.TO — annual report dated 2024-09-30
Total revenue: 18810480
Gross profit: 11401260
Operating income: 2886500
Net income: 2607540
Capital expenditures: 1211960
Operating cash flow: 3220459.259259259
Depreciation & amortization: 1194676.2962962962
Net tangible assets: 17835763.7037037
Owner earnings: 2590256.296296296
Return on net tangible assets (%): 14.52282245563959
Capex to operating income (%): 41.9871817079508
Buffett classification: The Good
Stock price: 0.2518518518518518
P/E ratio: 13.28068630600887
Shares outstanding: 137501156
Book value: 20961057.777777776
P/B ratio: 1.6521075003707049
Market cap (USD): 34629920.770370364
Debt to equity: 0.2260581421039396
Current ratio: 7.146166131832538
Quick ratio: 5.241969976629113
Effective tax rate (%): 4.101704777944079
Interest coverage ratio: 4.227468742372054
COGS to revenue (%): 39.38878752695306
R&D to revenue (%): 8.369573966411473
SG&A to revenue (%): 36.896469218026134
Free cash flow (dilution-adjusted): 1278948.1481481479
Buyback yield (%): 1.979189777524061
Retained earnings: -24734248.148148146
Inventory turnover: 1.5473108360906112
Receivables turnover: 6.062468800335757
Capitalized R&D asset: 3023548.525817788
ROCI (R&D-adjusted, %): 10.417890067380975
Rosenberg metric: 3.864861682480433
FCF margin (%): 6.799125530811271
Revenue growth (%): 53.76622728640099
Rule of 40 score: 60.56535281721226
Financial ratios for MBX.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 250333.56643356645
Buffett classification: The Gruesome
Stock price: 0.2867132867132867
Shares outstanding: 137501156
Market cap (USD): 39423408.36363637
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MBX.TO — quarterly report dated 2025-03-31
Total revenue: 3723681.118881119
Gross profit: 2215690.20979021
Operating income: 207863.63636363638
Net income: 14450.349650349652
Capital expenditures: 171530.76923076925
Operating cash flow: 695141.2587412588
Depreciation & amortization: 299330.76923076925
Net tangible assets: 18944054.545454547
Owner earnings: 142250.34965034964
Return on net tangible assets (%): 0.7508970654039915
Capex to operating income (%): 82.52081616175208
Buffett classification: The Gruesome
Stock price: 0.30069930069930073
P/E ratio: 715.3200866240805
Shares outstanding: 137501156
Book value: 21723736.363636367
P/B ratio: 1.903286836225645
Market cap (USD): 41346501.45454546
Debt to equity: 0.17224074739168196
Current ratio: 9.360296173475923
Quick ratio: 6.374818400015298
Interest coverage ratio: 1.1831824062095733
COGS to revenue (%): 40.49731598778861
R&D to revenue (%): 9.57277030925109
SG&A to revenue (%): 44.34770540618502
Free cash flow (dilution-adjusted): 417521.6783216783
Buyback yield (%): 1.2588004105791442
Retained earnings: -22736789.510489512
Inventory turnover: 0.26058240235260766
Receivables turnover: 2.118501455139337
Capitalized R&D asset: 356459.4405594406
ROCI (R&D-adjusted, %): 1.7165799084752502
FCF margin (%): 11.212605617720941
Rule of 40 score: 11.212605617720941
Financial ratios for MBX.TO — quarterly report dated 2025-06-30
Total revenue: 2534439.416058394
Gross profit: 1032821.1678832116
Operating income: -970521.8978102189
Net income: -1199106.5693430656
Capital expenditures: 142081.02189781022
Operating cash flow: -1404156.2043795618
Depreciation & amortization: 324705.10948905104
Net tangible assets: 18586260.583941605
Owner earnings: -1016482.4817518247
Return on net tangible assets (%): -5.468999410403502
Buffett classification: The Gruesome
Stock price: 0.218978102189781
Shares outstanding: 137501156
Book value: 21398555.474452555
P/B ratio: 1.4070922789965254
Market cap (USD): 30109742.18978102
Debt to equity: 0.21849602304487362
Current ratio: 9.73133414240854
Quick ratio: 6.154045254919249
Interest coverage ratio: -5.906223764109079
COGS to revenue (%): 59.248535935040266
R&D to revenue (%): 17.037211759061016
SG&A to revenue (%): 62.00760789612987
Free cash flow (dilution-adjusted): -1663412.4087591239
Buyback yield (%): 0.6464794133561078
Retained earnings: -24931667.883211676
Inventory turnover: 0.23217596924088835
Receivables turnover: 1.4500516386770976
Capitalized R&D asset: 670625.6353938032
ROCI (R&D-adjusted, %): -2.9920769039995783
Rosenberg metric: -3.318383264167614
FCF margin (%): -65.63236028526154
Revenue growth (%): -31.937259525060103
Rule of 40 score: -97.56961981032164
Financial ratios for MBX.TO — quarterly report dated 2025-09-30
Total revenue: 2693753.956834533
Gross profit: 1091717.985611511
Operating income: -1012233.0935251799
Net income: -1065224.4604316547
Capital expenditures: 111010.79136690649
Operating cash flow: 60397.84172661871
Depreciation & amortization: 339226.618705036
Net tangible assets: 17307049.64028777
Owner earnings: -837008.6330935252
Return on net tangible assets (%): -4.836229458457876
Buffett classification: The Gruesome
Stock price: 0.19424460431654678
Shares outstanding: 137501156
Book value: 19991037.410071943
P/B ratio: 1.3360416016645158
Market cap (USD): 26708857.64028777
Debt to equity: 0.24379810204155516
Current ratio: 8.483371615137067
Quick ratio: 5.1743606315040225
Interest coverage ratio: -5.790163745529816
COGS to revenue (%): 59.472245679987644
R&D to revenue (%): 16.739016290817176
SG&A to revenue (%): 84.96986634148061
Free cash flow (dilution-adjusted): -166102.1582733813
Buyback yield (%): 0.5612020158283318
Retained earnings: -25638163.30935252
Inventory turnover: 0.24216292469017198
Receivables turnover: 2.3249283301117845
Capitalized R&D asset: 857844.0619003956
ROCI (R&D-adjusted, %): -3.780738733948752
Rosenberg metric: 0.13639906533669285
FCF margin (%): -6.166196354048988
Revenue growth (%): 6.285987337740647
Rule of 40 score: 0.11979098369165975
Financial ratios for MBX.TO — annual report dated 2025-09-30
Total revenue: 13370766.906474821
Gross profit: 7088899.28057554
Operating income: -1133923.7410071944
Net income: -1615692.0863309354
Capital expenditures: 573594.964028777
Operating cash flow: -57760.431654676264
Depreciation & amortization: 1280112.2302158275
Net tangible assets: 17307049.64028777
Owner earnings: -909174.8201438849
Return on net tangible assets (%): -5.253205133401163
Buffett classification: The Gruesome
Stock price: 0.19424460431654678
Shares outstanding: 137501156
Book value: 19991037.410071943
P/B ratio: 1.3360416016645158
Market cap (USD): 26708857.64028777
Debt to equity: 0.24379810204155516
Current ratio: 8.483371615137067
Quick ratio: 5.1743606315040225
Interest coverage ratio: -1.6583902560152861
COGS to revenue (%): 46.982104092004434
R&D to revenue (%): 12.52417089875981
SG&A to revenue (%): 48.97434357762984
Free cash flow (dilution-adjusted): -1099120.8633093527
Buyback yield (%): 4.661471920845362
Retained earnings: -25638163.30935252
Inventory turnover: 0.9495638450882847
Receivables turnover: 11.54005721172623
Capitalized R&D asset: 3229711.1348787635
ROCI (R&D-adjusted, %): -3.722601678431689
Rosenberg metric: -2.7391250002225584
FCF margin (%): -8.22032775679532
Revenue growth (%): -28.918523575821446
Rule of 40 score: -37.13885133261677
Financial ratios for MBX.TO — quarterly report dated 2025-12-31
Total revenue: 3079495.620437956
Gross profit: 1265304.3795620436
Operating income: -692842.3357664233
Net income: -851954.01459854
Capital expenditures: 124354.74452554743
Operating cash flow: -1899564.2335766421
Depreciation & amortization: 333061.3138686131
Net tangible assets: 16787251.824817516
Owner earnings: -643247.4452554744
Return on net tangible assets (%): -3.831761457849381
Buffett classification: The Gruesome
Stock price: 0.1678832116788321
Shares outstanding: 137501156
Book value: 19421296.35036496
P/B ratio: 1.1885991162684835
Market cap (USD): 23084135.678832114
Debt to equity: 0.25808154161118035
Current ratio: 7.511853076942387
Quick ratio: 4.476175991826161
Interest coverage ratio: -3.770877612556959
COGS to revenue (%): 58.91196041441046
R&D to revenue (%): 13.204029762196814
SG&A to revenue (%): 50.382575210795025
Free cash flow (dilution-adjusted): -2141094.1605839417
Buyback yield (%): 0.5493044727565782
Retained earnings: -26864397.080291968
Inventory turnover: 0.26692248005820773
Receivables turnover: 1.0588581202415925
Capitalized R&D asset: 851219.0977787114
ROCI (R&D-adjusted, %): -2.8277197044640743
Rosenberg metric: 0.38497083038097457
FCF margin (%): -69.52742995878793
Revenue growth (%): 14.319855108694243
Rule of 40 score: -55.20757485009369
Financial ratios for MGRX — annual report dated 2023-12-31
Total revenue: 731493
Gross profit: 431501
Operating income: -9218890
Net income: -9212417
Capital expenditures: 3519
Operating cash flow: -6997375
Depreciation & amortization: 79868
Net tangible assets: 774754
Owner earnings: -9136068
Return on net tangible assets (%): -1179.2217916912982
Buffett classification: The Gruesome
Stock price: 4.16
Shares outstanding: 17167422
Book value: 774754
P/B ratio: 92.1795505670187
Market cap (USD): 71416475.52
Debt to equity: 0.1660901395797892
Current ratio: 3.9577881162413893
Quick ratio: 3.870138053231507
COGS to revenue (%): 41.01091876477287
SG&A to revenue (%): 1168.8322376290682
Free cash flow (dilution-adjusted): -7625357
Buyback yield (%): 0
Retained earnings: -11228173
Inventory turnover: 16.214907302307985
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1097.859392770166
FCF margin (%): -1042.4374532633942
Revenue growth (%): 8083.163664839468
Rule of 40 score: 7040.726211576073
Financial ratios for MGRX — quarterly report dated 2024-09-30
Capital expenditures: 65000
Buffett classification: The Gruesome
Stock price: 3.54
Shares outstanding: 17167422
Market cap (USD): 60772673.88
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MGRX — annual report dated 2024-12-31
Total revenue: 615873
Gross profit: 379964
Operating income: -8693526
Net income: -8706145
Capital expenditures: 0
Operating cash flow: -4863776
Depreciation & amortization: 731469
Net tangible assets: -1286488
Owner earnings: -7974676
Buffett classification: The Gruesome
Stock price: 2.42
Shares outstanding: 17167422
Book value: 13945048
P/B ratio: 2.9792053236389
Market cap (USD): 41545161.24
Debt to equity: 0.015414934391046915
Current ratio: 0.05303189209400735
Quick ratio: 0.05303189209400735
Interest coverage ratio: -634.5639416058394
COGS to revenue (%): 38.30481284290755
SG&A to revenue (%): 1282.4410227433252
Free cash flow (dilution-adjusted): -5112458
Buyback yield (%): 0
Retained earnings: -20004486
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -62.341312844530904
FCF margin (%): -830.1156244875161
Revenue growth (%): -15.806029586065758
Rule of 40 score: -845.9216540735819
Financial ratios for MGRX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.42
Shares outstanding: 17167422
Market cap (USD): 41545161.24
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MGRX — quarterly report dated 2025-03-31
Total revenue: 109306
Gross profit: 62064
Operating income: -4576374
Net income: -4839391
Capital expenditures: 0
Operating cash flow: -2274781
Depreciation & amortization: 414992
Net tangible assets: -1279035
Owner earnings: -4424399
Buffett classification: The Gruesome
Stock price: 1.95
Shares outstanding: 17167422
Book value: 20250661
P/B ratio: 1.6531051949365998
Market cap (USD): 33476472.9
Debt to equity: 0.002356120622433016
Current ratio: 0.11751760914744318
Quick ratio: 0.11751760914744318
Interest coverage ratio: -16.532247168686666
COGS to revenue (%): 43.21995132929574
SG&A to revenue (%): 2945.344262894992
Free cash flow (dilution-adjusted): -2325760
Buyback yield (%): 0
Retained earnings: -25939986
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -22.598640113525185
FCF margin (%): -2127.7514500576362
Rule of 40 score: -2127.7514500576362
Financial ratios for MGRX — quarterly report dated 2025-06-30
Total revenue: 168109
Gross profit: 89948
Operating income: -5268495
Net income: -5415818
Capital expenditures: 0
Operating cash flow: -1256449
Depreciation & amortization: 836234
Net tangible assets: -1451829
Owner earnings: -4579584
Buffett classification: The Gruesome
Stock price: 1.52
Shares outstanding: 17167422
Book value: 19241883
P/B ratio: 1.3561293060559614
Market cap (USD): 26094481.44
Debt to equity: 0.032747158892921235
Current ratio: 0.07368210650584499
Quick ratio: 0.07368210650584499
Interest coverage ratio: -242.7877880184332
COGS to revenue (%): 46.49423885693211
SG&A to revenue (%): 3124.427008666996
Free cash flow (dilution-adjusted): -1307428
Buyback yield (%): 0
Retained earnings: -31649804
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -27.38035045738507
FCF margin (%): -777.7263561141879
Revenue growth (%): 53.79668087753646
Rule of 40 score: -723.9296752366514
Financial ratios for MGRX — quarterly report dated 2025-09-30
Total revenue: 84246
Gross profit: 50899
Operating income: -7542926
Net income: -7618218
Capital expenditures: 0
Operating cash flow: -1241264
Depreciation & amortization: 24828
Net tangible assets: -191053
Owner earnings: -7593390
Buffett classification: The Gruesome
Stock price: 2.19
Shares outstanding: 17167422
Book value: 15727527
P/B ratio: 2.3905000563661405
Market cap (USD): 37596654.18
Debt to equity: 0.007131890474580015
Current ratio: 0.7438040471231855
Quick ratio: 0.7438040471231855
Interest coverage ratio: -99.44529993408042
COGS to revenue (%): 39.58288820834224
SG&A to revenue (%): 8974.320442513592
Free cash flow (dilution-adjusted): -2341057
Buyback yield (%): 0
Retained earnings: -37877913
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -47.96002575611538
FCF margin (%): -2778.8346034233077
Revenue growth (%): -49.88608581337109
Rule of 40 score: -2828.720689236679
Financial ratios for MGRX — annual report dated 2025-12-31
Total revenue: 456021
Gross profit: 250386
Operating income: -19154988
Net income: -20642994
Capital expenditures: 0
Operating cash flow: -5850255
Depreciation & amortization: 1724203
Net tangible assets: 968063
Owner earnings: -18918791
Return on net tangible assets (%): -1954.2933672705185
Buffett classification: The Gruesome
Stock price: 0.74
Shares outstanding: 17167422
Book value: 15199005
P/B ratio: 0.8358371011786626
Market cap (USD): 12703892.28
Debt to equity: 0.02025283891938979
Current ratio: 1.7375809595673772
Quick ratio: 1.7375809595673772
Interest coverage ratio: -185.04910494334044
COGS to revenue (%): 45.09331807087831
SG&A to revenue (%): 3666.833106370101
Free cash flow (dilution-adjusted): -7018535
Buyback yield (%): 0
Retained earnings: -40647480
Receivables turnover: 22.737385321100916
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -126.0279077479085
FCF margin (%): -1539.0815335258683
Revenue growth (%): -25.95535118441627
Rule of 40 score: -1565.0368847102845
Financial ratios for MGRX — quarterly report dated 2025-12-31
Total revenue: 94360
Gross profit: 47475
Operating income: -1490378
Net income: -2769370
Capital expenditures: 0
Operating cash flow: -1077761
Depreciation & amortization: 448149
Net tangible assets: 968063
Owner earnings: -2321221
Return on net tangible assets (%): -239.77995233781272
Buffett classification: The Gruesome
Stock price: 0.74
Shares outstanding: 17167422
Book value: 15199005
P/B ratio: 0.8358371011786626
Market cap (USD): 12703892.28
Debt to equity: 0.02025283891938979
Current ratio: 1.7375809595673772
Quick ratio: 1.7375809595673772
Interest coverage ratio: -75.79606367288817
COGS to revenue (%): 49.68736752861382
SG&A to revenue (%): 436.97223399745656
Free cash flow (dilution-adjusted): -1044290
Buyback yield (%): 0
Retained earnings: -40647480
Receivables turnover: 4.704826485839649
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.805760311283535
FCF margin (%): -1106.708350996185
Revenue growth (%): 12.005317759893645
Rule of 40 score: -1094.7030332362913
Financial ratios for MSEX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 109.78
Shares outstanding: 18624329
Market cap (USD): 2044578837.6200001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MSEX — annual report dated 2022-12-31
Total revenue: 162434000
Gross profit: 83338000
Operating income: 42101000
Net income: 42429000
Capital expenditures: 91335000
Operating cash flow: 61361000
Depreciation & amortization: 27475000
Net tangible assets: 402412000
Owner earnings: -21431000
Return on net tangible assets (%): -5.325636412433029
Capex to operating income (%): 216.94259043728178
Buffett classification: The Gruesome
Stock price: 72.73
P/E ratio: 31.925038256145562
Shares outstanding: 18624329
Book value: 402412000
P/B ratio: 3.3660712110225344
Market cap (USD): 1354547448.17
Debt to equity: 0.911871415365347
Current ratio: 0.3165307698181726
Quick ratio: 0.2641206865831205
Effective tax rate (%): 7.094528016816659
Interest coverage ratio: 5.96923295051751
COGS to revenue (%): 48.6942388908726
Free cash flow (dilution-adjusted): -31604000
Buyback yield (%): 0
Retained earnings: 167274000
Inventory turnover: 12.804921482920511
Receivables turnover: 6.582404668314625
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.401149498584035
FCF margin (%): -19.456517724121795
Rule of 40 score: -19.456517724121795
Financial ratios for MSEX — annual report dated 2023-12-31
Total revenue: 166274000
Gross profit: 83161000
Operating income: 39223000
Net income: 31524000
Capital expenditures: 90179000
Operating cash flow: 52782000
Depreciation & amortization: 29442000
Net tangible assets: 425075000
Owner earnings: -29213000
Return on net tangible assets (%): -6.8724342763041815
Capex to operating income (%): 229.9135711189863
Buffett classification: The Gruesome
Stock price: 61.68
P/E ratio: 36.44044577845451
Shares outstanding: 18624329
Book value: 425075000
P/B ratio: 2.7024610073986945
Market cap (USD): 1148748612.72
Debt to equity: 0.9685490795741928
Current ratio: 1.0453341551974882
Quick ratio: 0.9781852854212214
Effective tax rate (%): 3.196683555964993
Interest coverage ratio: 3.6622782446311857
COGS to revenue (%): 49.98556599348064
Free cash flow (dilution-adjusted): -39611000
Buyback yield (%): 0
Retained earnings: 176227000
Inventory turnover: 11.92096959265634
Receivables turnover: 1.7081599737007016
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.46424688422687
FCF margin (%): -23.822726343264733
Revenue growth (%): 2.364037085831784
Rule of 40 score: -21.45868925743295
Financial ratios for MSEX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 62.38
Shares outstanding: 18624329
Market cap (USD): 1161785643.02
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MSEX — annual report dated 2024-12-31
Total revenue: 191877000
Gross profit: 99514000
Operating income: 53210000
Net income: 44351000
Capital expenditures: 74622000
Operating cash flow: 58730000
Depreciation & amortization: 28038000
Net tangible assets: 446898000
Owner earnings: -2233000
Return on net tangible assets (%): -0.4996665905866663
Capex to operating income (%): 140.24055628641233
Buffett classification: The Gruesome
Stock price: 50.58
P/E ratio: 21.240074875876527
Shares outstanding: 18624329
Book value: 446898000
P/B ratio: 2.1079050718956003
Market cap (USD): 942018560.8199999
Debt to equity: 0.863653451123075
Current ratio: 0.5184465785155873
Quick ratio: 0.43738538751085804
Effective tax rate (%): 13.471593569533322
Interest coverage ratio: 4.167123502231968
COGS to revenue (%): 48.13656665467982
Free cash flow (dilution-adjusted): -17429000
Buyback yield (%): 0
Retained earnings: 197061000
Inventory turnover: 13.746539663640423
Receivables turnover: 6.481017361345673
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.538994750427797
FCF margin (%): -9.083423234676381
Revenue growth (%): 15.398077871465171
Rule of 40 score: 6.31465463678879
Financial ratios for MSEX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 50.58
Shares outstanding: 18624329
Market cap (USD): 942018560.8199999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MSEX — quarterly report dated 2025-03-31
Total revenue: 44301000
Gross profit: 23192000
Operating income: 11557000
Net income: 9479000
Capital expenditures: 18911000
Operating cash flow: 13782000
Depreciation & amortization: 7913000
Net tangible assets: 450662000
Owner earnings: -1519000
Return on net tangible assets (%): -0.33705970328095114
Capex to operating income (%): 163.63243056156443
Buffett classification: The Gruesome
Stock price: 62.02
P/E ratio: 30.464207315645115
Shares outstanding: 18624329
Book value: 450662000
P/B ratio: 2.563075840829713
Market cap (USD): 1155080884.5800002
Debt to equity: 0.877038667560167
Current ratio: 0.45937561746690375
Quick ratio: 0.38991306065994863
Effective tax rate (%): 10.920026313316418
Interest coverage ratio: 4.259859933652783
COGS to revenue (%): 47.649037267781765
Free cash flow (dilution-adjusted): -5518000
Buyback yield (%): 0
Retained earnings: 200437000
Inventory turnover: 3.002275636467074
Receivables turnover: 1.457030093734583
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9812853590050784
FCF margin (%): -12.45570077424889
Rule of 40 score: -12.45570077424889